We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?
- Authors
Nagar, Sarosh; Rand, Leah Z.; Kesselheim, Aaron S.
- Abstract
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation for Economic Co-operation and Development member nations: the United Kingdom, Germany, and Canada. Specifically, this article compares these countries' policies on list and net price disclosures and on how international reference pricing is used to evaluate merits and drawbacks of different pricing transparency approaches. Finally, the article summarizes what policymakers in the United States should learn from these comparisons.
- Subjects
UNITED States; MEDICAL care costs; COST effectiveness; POLICY sciences; MEDICAL prescriptions; DRUG development; ECONOMICS
- Publication
AMA Journal of Ethics, 2022, Vol 24, Issue 11, p1083
- ISSN
2376-6980
- Publication type
Article
- DOI
10.1001/amajethics.2022.1083